Cargando…
Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation
OBJECTIVES: We postulated that combining high-dose simvastatin with bone marrow derived-mesenchymal stem cells (MSCs) delivery may give better prognosis in a mouse hindlimb ischemia model. METHODS: Mouse hindlimb ischemia model was established by ligating the right femoral artery. Animals were group...
Autores principales: | Li, Yong, Zhang, Dingguo, Zhang, Yuqing, He, Guoping, Zhang, Fumin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946286/ https://www.ncbi.nlm.nih.gov/pubmed/20846454 http://dx.doi.org/10.1186/1423-0127-17-75 |
Ejemplares similares
-
Correction: Augmentation of Neovascularization in Hindlimb Ischemia by Combined Transplantation of Human Embryonic Stem Cells-Derived Endothelial and Mural Cells
por: Yamahara, Kenichi, et al.
Publicado: (2009) -
Murine Model of Hindlimb Ischemia
por: Niiyama, Hiroshi, et al.
Publicado: (2009) -
Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model
por: Yao, Ziping, et al.
Publicado: (2020) -
Intravenous infusion of bone marrow-derived mesenchymal stem cells improves tissue perfusion in a rat hindlimb ischemia model
por: Maeda, Shusaku, et al.
Publicado: (2022) -
Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model
por: van Rhijn-Brouwer, Femke Christina Ching-Chuan, et al.
Publicado: (2022)